BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 17157668)

  • 1. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.
    Williamson MP; McCormick TG; Nance CL; Shearer WT
    J Allergy Clin Immunol; 2006 Dec; 118(6):1369-74. PubMed ID: 17157668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
    Hamza A; Zhan CG
    J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding.
    Kawai K; Tsuno NH; Kitayama J; Okaji Y; Yazawa K; Asakage M; Hori N; Watanabe T; Takahashi K; Nagawa H
    J Allergy Clin Immunol; 2003 Nov; 112(5):951-7. PubMed ID: 14610487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antifolate activity of tea catechins.
    Navarro-Perán E; Cabezas-Herrera J; García-Cánovas F; Durrant MC; Thorneley RN; Rodríguez-López JN
    Cancer Res; 2005 Mar; 65(6):2059-64. PubMed ID: 15781612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A receptor for green tea polyphenol EGCG.
    Tachibana H; Koga K; Fujimura Y; Yamada K
    Nat Struct Mol Biol; 2004 Apr; 11(4):380-1. PubMed ID: 15024383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG].
    Lam WH; Kazi A; Kuhn DJ; Chow LM; Chan AS; Dou QP; Chan TH
    Bioorg Med Chem; 2004 Nov; 12(21):5587-93. PubMed ID: 15465336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R; Sasaki K; Yoshida K
    Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin gallate attenuates adhesion and migration of CD8+ T cells by binding to CD11b.
    Kawai K; Tsuno NH; Kitayama J; Okaji Y; Yazawa K; Asakage M; Hori N; Watanabe T; Takahashi K; Nagawa H
    J Allergy Clin Immunol; 2004 Jun; 113(6):1211-7. PubMed ID: 15208607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gap junctional intercellular communication by the green tea polyphenol (-)-epigallocatechin gallate in normal rat liver epithelial cells.
    Kang NJ; Lee KM; Kim JH; Lee BK; Kwon JY; Lee KW; Lee HJ
    J Agric Food Chem; 2008 Nov; 56(21):10422-7. PubMed ID: 18828601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.
    Biorn AC; Cocklin S; Madani N; Si Z; Ivanovic T; Samanen J; Van Ryk DI; Pantophlet R; Burton DR; Freire E; Sodroski J; Chaiken IM
    Biochemistry; 2004 Feb; 43(7):1928-38. PubMed ID: 14967033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of green tea polyphenols in the inhibition of collagenolytic activity by collagenase.
    Madhan B; Krishnamoorthy G; Rao JR; Nair BU
    Int J Biol Macromol; 2007 Jun; 41(1):16-22. PubMed ID: 17207851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation suppresses the proteasome-inhibitory function of green tea polyphenols.
    Landis-Piwowar KR; Wan SB; Wiegand RA; Kuhn DJ; Chan TH; Dou QP
    J Cell Physiol; 2007 Oct; 213(1):252-60. PubMed ID: 17477351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
    Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
    Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor.
    Van Aller GS; Carson JD; Tang W; Peng H; Zhao L; Copeland RA; Tummino PJ; Luo L
    Biochem Biophys Res Commun; 2011 Mar; 406(2):194-9. PubMed ID: 21300025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects.
    Yamamoto T; Lewis J; Wataha J; Dickinson D; Singh B; Bollag WB; Ueta E; Osaki T; Athar M; Schuster G; Hsu S
    J Pharmacol Exp Ther; 2004 Jan; 308(1):317-23. PubMed ID: 14569057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate.
    Weinreb O; Amit T; Youdim MB
    Free Radic Biol Med; 2007 Aug; 43(4):546-56. PubMed ID: 17640565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of dystrophic muscle cells with polyphenols from green tea correlates with improved glutathione balance and increased expression of 67LR, a receptor for (-)-epigallocatechin gallate.
    Dorchies OM; Wagner S; Buetler TM; Ruegg UT
    Biofactors; 2009; 35(3):279-94. PubMed ID: 19322813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation.
    Ishii T; Mori T; Tanaka T; Mizuno D; Yamaji R; Kumazawa S; Nakayama T; Akagawa M
    Free Radic Biol Med; 2008 Nov; 45(10):1384-94. PubMed ID: 18771724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The crystal structure of the green tea polyphenol (-)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site.
    Miyata M; Sato T; Kugimiya M; Sho M; Nakamura T; Ikemizu S; Chirifu M; Mizuguchi M; Nabeshima Y; Suwa Y; Morioka H; Arimori T; Suico MA; Shuto T; Sako Y; Momohara M; Koga T; Morino-Koga S; Yamagata Y; Kai H
    Biochemistry; 2010 Jul; 49(29):6104-14. PubMed ID: 20565072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design.
    Smith DM; Daniel KG; Wang Z; Guida WC; Chan TH; Dou QP
    Proteins; 2004 Jan; 54(1):58-70. PubMed ID: 14705024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.